AstraZeneca (NYSE: AZN) announced it has entered into a licensing agreement with China Medical System Holdings Ltd (CMS) for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE